-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Classify Risk Based On Clinical and Molecular Modeling: Integrating molecular markers in the risk assessment of myelodysplastic syndrome

Program: Education Program
Session: Are We Personalizing MDS Therapy in 2023?
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Clinical Research
Saturday, December 9, 2023, 9:30 AM-10:45 AM

Rena R. Xian, MD

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

Disclosures: Xian: Invivoscribe: Honoraria.

See more of: Are We Personalizing MDS Therapy in 2023?
See more of: Education Program
Previous Presentation | Next Presentation >>